friendly language for distribution with each antidepressant prescription or refill. To make sure patients receive the pamphlet, the FDA told manufacturers to devise special packaging that contains only one course of therapy, rather than distributing the drugs in bulk. Patients will get a container sealed by the drug maker with the pamphlet included. Drug companies will need to convey the information in the black box in television and print advertisements. They also will be forbidden from running "reminder ads" for the drugs that mention the product name but do not explain benefits and risks, FDA officials said. --More 0124 Local Time 2224 GMT
